Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era.

MLA

Correia, Cristina, et al. “Relationship between BCL2 Mutations and Follicular Lymphoma Outcome in the Chemoimmunotherapy Era.” Blood Cancer Journal, vol. 13, no. 1, May 2023, p. 81. EBSCOhost, https://doi.org/10.1038/s41408-023-00847-1.

APA

Correia, C., Maurer, M. J., McDonough, S. J., Schneider, P. A., Ross, P. E., Novak, A. J., Feldman, A. L., Cerhan, J. R., Slager, S. L., Witzig, T. E., Eckloff, B. W., Li, H., Nowakowski, G. S., & Kaufmann, S. H. (2023). Relationship between BCL2 mutations and follicular lymphoma outcome in the chemoimmunotherapy era. Blood Cancer Journal, 13(1), 81. https://doi.org/10.1038/s41408-023-00847-1

Chicago

Correia, Cristina, Matthew J Maurer, Samantha J McDonough, Paula A Schneider, Paige E Ross, Anne J Novak, Andrew L Feldman, et al. 2023. “Relationship between BCL2 Mutations and Follicular Lymphoma Outcome in the Chemoimmunotherapy Era.” Blood Cancer Journal 13 (1): 81. doi:10.1038/s41408-023-00847-1.